Lysicamine: a Potential Redifferentiation Agent for Thyroid Cancer Cells Identified via a Non-radioactive Iodide Uptake Screening

LY294002 - Eli Lilly

CI-1040 - Pfizer

https://www.endocrine-abstracts.org/ea/0119/ea0119ps1-03-05

Camila da Silva Neves 1; Guilherme Henrique 2; João Jaze Alves 2; Renata Da Silva 3; Kelly De Oliveira 3; Rodrigo Tamura 2; Caroline Serrano-Nascimento 3; Ileana Rubio 4

Sep 9, 2026